Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
08/2005
08/25/2005WO2005077936A1 Pyridine benzimidazole sulfoxides with high purity
08/25/2005WO2005077935A1 Piperidinylcarbonyl-pyrrolidines and their use as melanocortin agonists
08/25/2005WO2005077934A1 Anthranilamides, process for the production thereof, and pest controllers containing the same
08/25/2005WO2005077933A1 Novel polymorphic form of imatinib mesylate and a process for its preparation
08/25/2005WO2005077932A2 Chemokine receptor antagonists
08/25/2005WO2005077931A2 Method for the production of 1-[n2-[3,5-dibromo-n-[[4-(3,4-dihydro-2(1h)-oxoquinazoline-3-yl)-1-piperidinyl]carbonyl]-d-tyrosyl]-l-lysyl]-4-(4-pyridinyl)-piperazine
08/25/2005WO2005077922A2 Process for the preparation of substituted triazole compounds
08/25/2005WO2005077918A1 Pth agonists
08/25/2005WO2005077915A1 Pyridazinones as antagonists of a4 integrins
08/25/2005WO2005077914A1 PYRIDAZINONE UREAS AS ANTAGONISTS OF α4 INTEGRINS
08/25/2005WO2005077912A1 Indazole compound and pharmaceutical use thereof
08/25/2005WO2005077907A1 Tetrahydrobenzo[d]azepin-2- one derivatives and the use thereof for treating cardiovascular diseases
08/25/2005WO2005077905A1 Fused-ring 4-oxopyrimidine derivative
08/25/2005WO2005077903A2 Melanin concentrating hormone receptor ligands: substituted tetrahydroisoquinoline analogues
08/25/2005WO2005077902A2 Methods for the synthesis of pyridoxamine
08/25/2005WO2005077900A1 Bicyclic amide derivatives
08/25/2005WO2005077898A1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
08/25/2005WO2005077895A1 Thioamides and salts thereof and cytokine production inhibitors containing both
08/25/2005WO2005077463A2 Ligand for a monoamine receptor or transporter for treating addiction or dependence
08/25/2005WO2005077369A1 Piperidine derivatives useful as ccr3 antagonists
08/25/2005WO2005076854A2 Pyrimidinone compounds useful as kinase inhibitors
08/25/2005WO2005051942A8 Indazole compounds and methods of use thereof as protein kinase inhibitors
08/25/2005WO2004108687A3 Nitrogen-containing heteroaryl derivatives for the treatment of hcv-infection
08/25/2005WO2004106493A3 Chemokine receptor binding heterocyclic compounds with enhanced efficacy
08/25/2005WO2004069394A3 Synthetic method for direct arylation of heterocyclic arenes
08/25/2005US20050187390 Bicyclic heteroaryl derivatives
08/25/2005US20050187387 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
08/25/2005US20050187291 use of 2-(urea or thiourea)tetralins as analgesic or to treat pulmonary dysfunction
08/25/2005US20050187279 Indazole derivatives useful for the treatment of eating disorders, weight gain, obesity, abnormalities in reproduction and sexual behavior, thyroid hormone secretion, diuresis and water/electrolyte homeostasis, sensory processing, memory, sleeping, arousal, anxiety, depression, seizure etc.
08/25/2005US20050187277 Protein tyrosine phosphatase inhibitors; diseases including type I and type II diabetes, cancer, autoimmune diseases, AIDS; imidazole, oxazole and thiazole derivatives; e.g. 4-(4-(2,4-dichloro-phenyl)-2-(2-(3'-methanesulfonyl-biphenyl-4-yl)-(E)-vinyl)-imidazol-1-ylmethyl)-benzoic acid
08/25/2005US20050187273 Fused heterocyclic compounds and analogs thereof, modulators of nuclear hormone receptor function
08/25/2005US20050187270 16-Halogen-epothilone derivatives, method for producing them and their pharmaceutical use
08/25/2005US20050187266 2-Methyl-2-{3-[({[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]carbonyl}amino)methyl]phenoxy}propanoic acid; polycystic ovarian syndrome; polycystic obesity; dietetics; hypoglycemic agents; antilipemic and - cholesterol agents; hypertriglyceridemia; insulin resistance; metabolic disorders; PPAR modulators
08/25/2005US20050187256 New compounds useful for the synthesis of S- and R-omeprazole and a process for their preparation
08/25/2005US20050187252 Novel compounds as opioid receptor modulators
08/25/2005US20050187248 Making 4-((Z)-(4-bromophenyl)(ethoxyimino)methyl)-1'-((2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1,4'-bipiperidine; desalting an oxime intermediate, reacting with 2,4-dimethyl-3-(4-oxopiperidin-1-ylcarbonyl)pyridine-n-oxide, cyanation, organometallic; scale-up; chemokine receptor 5 (CCR5)
08/25/2005US20050187247 Inhibition of the Ras/Raf/MEK signaling cascade; tumors, strokes, osteoporosis, cancer, rheumatoid arthritis, inflammatory disease, polycystic kidney disease, and colonic polyps
08/25/2005US20050187236 Nitrogen-containing aromatic derivatives
08/25/2005US20050187235 Pyrimidine derivatives useful as selective COX-2 inhibitors
08/25/2005US20050187231 4-aminoquinazolines e.g. 4-(4-phenylbutylamino)quinazoline; antiproliferative agents; antitumor agents; hyperproliferative disorders, including tumors, such as breast, brain, and kidney tumors
08/25/2005US20050187222 Therapy for impotency, erectile dysfuction; benign prostatic hyperplasia; hypotensive agents; congestive heart failure; vision defects; neurodegenerative disorders; incotinence; cognition activators
08/25/2005US20050187218 Imidazole based kinase inhibitors
08/25/2005US20050187217 Sodium channel modulators; pain relievers; treating epilepsy, neurodegenerative disorders, psychiatric disorders, arrhythmia, movement disorders, autoimmune diseases, and incontinence; fused ring 4-aminopyrimidines e.g. 4-amino-5,6,7,8-tetrahydroquinazolines
08/25/2005US20050186630 Extended tethering approach for rapid identification of ligands
08/25/2005US20050186446 Phosphorescence; personal computer, portable telephone, television receiver
08/25/2005DE102004006325A1 New benzazepine derivatives useful for treating or preventing dyslipidemia, arteriosclerosis, restenosis and ischemia
08/25/2005DE102004006142A1 Neutrale und kationische Naphthalinderivate und diese Verbindungen enthaltende Färbemittel für Keratinfasern Neutral and cationic naphthalene derivatives and compositions containing these compounds stains for keratin fibers
08/25/2005DE102004006141A1 Aufhellende direktziehende Farbstoffe für Keratinfasern und diese Verbindungen enthaltende Färbemittel Brightening direct dyes for keratin fibers containing these compounds and dyes
08/25/2005CA2556239A1 Vanilloid receptor ligands and their use in treatments
08/25/2005CA2555825A1 Process for the preparation of substituted triazole compounds
08/25/2005CA2555685A1 Pyrimidine derivatives for use as vanilloid receptor ligands and their use in the treatment of pain
08/25/2005CA2555594A1 Pyridazinones as antagonists of a4 integrins
08/25/2005CA2555227A1 Pyridazinone ureas as antagonists of .alpha.4 integrins
08/25/2005CA2554996A1 Tetrahydrobenzo[d]azepin-2- one derivatives and the use thereof for treating cardiovascular diseases
08/25/2005CA2554465A1 Piperidine derivatives useful as ccr3 antagonists
08/25/2005CA2554378A1 Bicycloamide derivative
08/25/2005CA2552565A1 Aryloxyalkylcarbamate-type derivatives, preparation method thereof and use of same in therapeutics
08/24/2005EP1566380A1 Isoquinoline compounds and medicinal use thereof
08/24/2005EP1566379A1 QUINOLINE DERIVATIVES AND QUINAZOLINE DERIVATIVES INHIBITING AUTOPHOSPHORYLATION OF Flt3 AND MEDICINAL COMPOSITIONS CONTAINING THE SAME
08/24/2005EP1566378A1 Isoindoline derivative
08/24/2005EP1565467A1 Novel vitronectin receptor antagonist derivatives, method for preparing same, use thereof as medicines and pharmaceutical compositions containing same
08/24/2005EP1565456A1 1,2,4-triazole derivative, method for preparing the same, and pharmaceutical composition containing the same
08/24/2005EP1565455A1 Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
08/24/2005EP1565454A1 Pyrazine compounds as crf modulators
08/24/2005EP1565453A1 2- (4-benzyl)-1-piperidinyl)methyl]benzimidazole-5-ol derivatives as nr2b receptor antagonists
08/24/2005EP1565452A2 3-substituted-6-aryl pyridines as ligands of c5a receptors
08/24/2005EP1565446A1 Chk-, pdk- and akt-inhibitory pyrimidines, their production and use as pharmaceutical agents
08/24/2005EP1565442A1 Pyridine derivatives as cb2 receptor modulators
08/24/2005EP1565436A2 3-aminopyrrolidine derivatives as modulators of chemokine receptors
08/24/2005EP1565431A1 Cannabinoid receptor ligands
08/24/2005EP1565192A2 Method and compositions for temporarily incapaciting subjets
08/24/2005EP1565187A2 Methods of treating cancer and related methods
08/24/2005EP1565178A2 Method and compositions for treating persistent pulmonary hypertension using aralkyl ester soft drugs
08/24/2005EP1458713B1 Indolinone derivatives useful as protein kinase inhibitors
08/24/2005EP1409459A4 Ecl labels having improved non-specific binding properties, methods of using and kits containing the same
08/24/2005EP1370558B1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists
08/24/2005EP1292190B1 N-phenyl-4-(4-pyridyl)-2-pyrimidineamine derivatives
08/24/2005EP1242085B1 Benzimidazole compounds having nociceptin receptor affinity
08/24/2005EP1218341B1 Sulfonyl carboxamide derivatives, method for their production and their use as medicaments
08/24/2005EP1214304B1 Benzylidene-thiazolidinediones and analogues and their use in the treatment of diabetes
08/24/2005EP1158980B1 N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
08/24/2005EP1124804B1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors
08/24/2005EP1019075B1 Beta 2-adrenergic receptor agonists
08/24/2005CN1659239A Yellow anionic disazo dyes
08/24/2005CN1659165A Quinolinone derivatives
08/24/2005CN1659161A Piperidine derivatives having CCR3 antagonism
08/24/2005CN1659160A Pyrazolecarboxamide insecticides
08/24/2005CN1659156A Novel guanidinobenzamides
08/24/2005CN1659148A Aryloximes
08/24/2005CN1659147A Pyridazine derivatives
08/24/2005CN1659145A 3-cyanoquinolines as inhibitors of EGF-R and HER2 kinases
08/24/2005CN1659143A Nitrogen-containing heteroaryl compounds having HIV integrase inhibitory activity
08/24/2005CN1659141A 1-sulfonyl-4-aminoalkoxy indole derivatives as 5-ht6-receptor modulators for the treatment of cns-disorders
08/24/2005CN1658877A Basic non-peptide bradykinin antagonists and pharmaceutical compositions therefrom
08/24/2005CN1658875A 1-(4-piperidinyl) benzimidazolones as histamine H3 antagonists
08/24/2005CN1658874A (1-4-piperidinyl) benzimidazole derivatives useful as histamine H3 antagonists
08/24/2005CN1658873A New pharmaceutical compositions based on anticholinergics and p38 kinase inhibitors
08/24/2005CN1658866A Tri-substituted heteroaryls and methods of making and using the same
08/24/2005CN1658848A Methods for identification of modulators of angiogenesis, compounds discovered thereby, and methods of treatment using the compounds
08/24/2005CN1658847A Use of EP4 receptor ligands in the treatment of IL-6 involved diseases
1 ... 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 ... 1080